Abstract: A cleansing composition includes 25% to 35% by weight of a surfactant, 1.5% to 5% by weight of a co-surfactant, 5% to 9% by weight of water; and 50% to 60% by weight of a fatty acid and soap mixture, wherein the fatty acid to soap ratio is 2.3:1 to 1.8:1. A method of making cleansing bars includes heating the cleansing composition to a temperature sufficient to provide a molten composition, cooling the molten composition to form flakes and/or chips, refining the flakes and/or chips to form billets, and stamping and/or cutting the billets to form the cleansing bars. Another method of making cleansing bars includes heating the cleansing composition to a temperature sufficient to provide a molten composition, pouring the molten composition into a mold, cooling the molten composition until the cleansing bars are formed, and removing the cleansing bars from the mold.

Abstract: A bar composition comprising: a) 10%-60% synthetic (non-soap) surfactant; b) 0%-50% fatty acid and soap wherein total fatty acid soap is less than 60% of total synthetic surfactant; c) 6.8%-54% water-soluble structurant, selected from • polyalkylene oxides having MW 1,500-10,000, • PEO-PPO blockcopolymers, wherein the water soluble structurant has a melting point of 40-100° C. and further comprises polyalkylene oxides having MW 50,000-500,000, 1-5 wt %; d) 0.1%-4.8% alkali metal isethionate; e) 2.7%-13.5% water, wherein the sum of water, alkali metal isethionate and water-soluble structurant is 10%-60%, wherein based on the total amount of water, alkali metal isethionate and said water-soluble structurant, • water is present 4-27%, • alkali metal isethionate is present less than 8%, • water-soluble structurant is present 68-90%. Use of the composition for eliminating efflorescence.

Abstract: A bar composition comprising: a) 10%-60% synthetic (non-soap) surfactant; b) 0%-50% fatty acid and soap wherein total fatty acid soap is less than 60% of total synthetic surfactant; c) 6.8%-54% water-soluble structurant, selected from •polyalkylene oxides having MW 1,500-10,000, •PEO-PPO blockcopolymers, wherein the water soluble structurant has a melting point of 40-100° C. and further comprises polyalkylene oxides having MW 50,000-500,000, 1-5 wt %; d) 0.1%-4.8% alkali metal isethionate; e) 2.7%-13.5% water, wherein the sum of water, alkali metal isethionate and water-soluble structurant is 10%-60%, wherein based on the total amount of water, alkali metal isethionate and said water-soluble structurant, •water is present 4-27%, alkali metal isethionate is present less than 8%, water-soluble structurant is present 68-90%. Use of the composition for eliminating efflorescence.

Abstract: A scale system includes a frame for placement over a toilet and a net to catch waste, for example from bowel movements. A scale is connected to the frame to register a change in tension experienced by the frame as waste is received by the net. The resulting weight measurement may be shown on a digital display. Once the user is done, a release lever on the frame may be triggered to release the net and waste into the toilet.

Abstract: The present invention relates to a multiplex in vitro nucleic acid amplification method for identifying a species of the Mycobacterium tuberculosis complex present in a sample. The method includes detecting the presence or absence of a plurality of nucleic acid molecule targets in the sample in one reaction, wherein at least one of the nucleic acid molecule targets is present in the genome of one or more, but not all, of the species of the Mycobacterium tuberculosis complex. The invention also includes kits containing primers or probes for conducting this method, nucleic acids useful for performing this method and diagnostic techniques using these nucleic acids.

Abstract: The present invention use of to a portion of the RPS7 gene or its corresponding mRNA in a diagnostic assay for fungal and yeast species and sequences for use in such assays and methods.

Abstract: The present invention relates to a multiplex in vitro nucleic acid amplification method for identifying a species of the Mycobacterium tuberculosis complex present in a sample. The method includes detecting the presence or absence of a plurality of nucleic acid molecule targets in the sample in one reaction, wherein at least one of the nucleic acid molecule targets is present in the genome of one or more, but not all, of the species of the Mycobacterium tuberculosis complex. The invention also includes kits containing primers or probes for conducting this method, nucleic acids useful for performing this method and diagnostic techniques using these nucleic acids.

Abstract: The current invention relates to a diagnostic kit for a bacterial species and/or fungal and/or yeast species comprising at least one oligonucleotide probe capable of binding to at least a portion of the LepA and/or Guf1 genes or its corresponding mRNA.

Abstract: The present invention relates to a multiplex in vitro nucleic acid amplification method for identifying a species of the Mycobacterium tuberculosis complex present in a sample. The method includes detecting the presence or absence of a plurality of nucleic acid molecule targets in the sample in one reaction, wherein at least one of the nucleic acid molecule targets is present in the genome of one or more, but not all, of the species of the Mycobacterium tuberculosis complex. The invention also includes kits containing primers or probes for conducting this method, nucleic acids useful for performing this method and diagnostic techniques using these nucleic acids.

Abstract: A methanol synthesis process includes reacting a process gas containing hydrogen, carbon dioxide and carbon monoxide over a catalyst including shaped units formed from a reduced and passivated catalyst powder the powder including copper in the range 10-80% by weight, zinc oxide in the range 20-90% by weight, alumina in the range 5-60% by weight and optionally one or more oxidic promoter compounds selected from compounds of Mg, Cr, Mn, V, Ti, Zr, Ta, Mo, W, Si and rare earths in the range 0.01-10% by weight, to form a product gas, and condensing methanol, water and oxygenate by-products therefrom, wherein the total oxygenate by-product level in the condensate is below 500 ppm.

Abstract: Use of the ssrA gene or tmRNA, an RNA transcript of the ssrA gene, or fragments thereof as target regions in a nucleic acid probe assay for the detection and identification of prokaryotic and/or eukaryotic organisms is described. Nucleotide sequence alignment of tmRNA sequences from various organisms can be used to identify regions of homology and non-homology within the sequences which in turn can be used to design both genus specific and species specific oligonucleotide probes. These newly identified regions of homology and non-homology provide the basis of identifying and detecting organisms at the molecular level. Oligonucleotide probes identified in this way can be used to detect tmRNA in samples thereby giving an indication of the viability of non-viral organisms present in various sample types.

Abstract: Use of the ssrA gene or tmRNA, an RNA transcript of the ssrA gene, or fragments thereof as target regions in a nucleic acid probe assay for the detection and identification of prokaryotic and/or eukaryotic organisms is described. Nucleotide sequence alignment of tmRNA sequences from various organisms can be used to identify regions of homology and non-homology within the sequences which in turn can be used to design both genus specific and species specific oligonucleotide probes. These newly identified regions of homology and non-homology provide the basis of identifying and detecting organisms at the molecular level. Oligonucleotide probes identified in this way can be used to detect tmRNA in samples thereby giving an indication of the viability of non-viral organisms present in various sample types.

Abstract: The present invention relates to a multiplex in vitro nucleic acid amplification method for identifying a species of the Mycobacterium tuberculosis complex present in a sample. The method includes detecting the presence or absence of a plurality of nucleic acid molecule targets in the sample in one reaction, wherein at least one of the nucleic acid molecule targets is present in the genome of one or more, but not all, of the species of the Mycobacterium tuberculosis complex. The invention also includes kits containing primers or probes for conducting this method, nucleic acids useful for performing this method and diagnostic techniques using these nucleic acids.

Abstract: A catalyst unit is described in the form of a cylinder having a length C and diameter D, which has two or more flutes running along its length, wherein said cylinder has domed ends of lengths A and B, such that (A+B+C)/D is in the range 0.50 to 2.00, and (A+B)/C is in the range 0.40 to 5.00. The catalyst may be used particularly in reactions where hydrogen is a reactant such as hydroprocessing, hydrogenation, water-gas shift reactions, methanation, hydrocarbon synthesis by the Fischer-Tropsch reaction, methanol synthesis and ammonia synthesis.

Abstract: A process for the synthesis of methanol comprises: (a) passing a synthesis gas mixture comprising a loop gas and a make-up gas through a first synthesis reactor containing a methanol synthesis catalyst, said reactor cooled by boiling water under pressure, to form a mixed gas containing methanol, (b) cooling the mixed gas containing methanol, (c) passing said cooled mixed gas containing methanol through a second synthesis reactor containing a methanol synthesis catalyst in which further methanol is synthesized to form a product gas stream, (d) cooling said product gas to condense methanol, (e) recovering said methanol and returning unreacted gas as the loop gas to said first synthesis reactor, wherein the mixed gas containing methanol from the first synthesis reactor is cooled in heat exchange with either said loop gas or said make up gas.

Abstract: Use of the ssrA gene or tmRNA, an RNA transcript of the ssrA gene, or fragments thereof as target regions in a nucleic acid probe assay for the detection and identification of prokaryotic and/or eukaryotic organisms is described. Nucleotide sequence alignment of tmRNA sequences from various organisms can be used to identify regions of homology and non-homology within the sequences which in turn can be used to design both genus specific and species specific oligonucleotide probes. These newly identified regions of homology and non-homology provide the basis of identifying and detecting organisms at the molecular level. Oligonucleotide probes identified in this way can be used to detect tmRNA in samples thereby giving an indication of the viability of non-viral organisms present in various sample types.

Abstract: A methanol synthesis process includes reacting a process gas containing hydrogen, carbon dioxide and carbon monoxide over a catalyst including shaped units formed from a reduced and passivated catalyst powder the powder including copper in the range 10-80% by weight, zinc oxide in the range 20-90% by weight, alumina in the range 5-60% by weight and optionally one or more oxidic promoter compounds selected from compounds of Mg, Cr, Mn, V, Ti, Zr, Ta, Mo, W, Si and rare earths in the range 0.01-10% by weight, to form a product gas, and condensing methanol, water and oxygenate by-products therefrom, wherein the total oxygenate by-product level in the condensate is below 500 ppm.

Abstract: A continuous positive airway pressure device which includes:—an inflatable breathable air reservoir provided with an air inlet/outlet;—a pressurized gas reservoir arranged to apply a predetermined substantially constant pressure on the breathable air reservoir, irrespective of the degree of inflation of the breathable air reservoir.

Abstract: The current invention relates to a diagnostic kit for a bacterial species and/or fungal and/or yeast species comprising at least one oligonucleotide probe capable of binding to at least a portion of the LepA and/or Guf1 genes or its corresponding mRNA.

Abstract: A catalyst unit is described in the form of a cylinder having a length C and diameter D, which has two or more flutes running along its length, wherein said cylinder has domed ends of lengths A and B, such that (A+B+C)/D is in the range 0.50 to 2.00, and (A+B)/C is in the range 0.40 to 5.00. The catalyst may be used particularly in reactions where hydrogen is a reactant such as hydroprocessing, hydrogenation, water-gas shift reactions, methanation, hydrocarbon synthesis by the Fischer-Tropsch reaction, methanol synthesis and ammonia synthesis.